Metraipolis › archive › dc_ceec16f74f25

FABP3 methylation as a novel biomarker for the differentiation and classification of benign and malignant thyroid nodules — Europe PMC PMID:41019337

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41019337
DOI
10.3389/fendo.2025.1630001
License (as archived)
solo-consultazione
Archived
2026-11-10T00:29:26.809Z
SHA-256 of the archived text
76ee443d9b93dfadb41a506a42804b57975e65b912440deee543a9990ce4d711
Stable URL of this page
https://metraipolis.com/documento/dc_ceec16f74f25

How to cite

FABP3 methylation as a novel biomarker for the differentiation and classification of benign and malignant thyroid nodules — Europe PMC PMID:41019337 — Europe PMC (en), https://europepmc.org/article/MED/41019337 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ceec16f74f25 (Metraipolis archive dc_ceec16f74f25, sha256 76ee443d9b93dfadb41a506a42804b57975e65b912440deee543a9990ce4d711)
BibTeX
@misc{dcceec16f74f25,
  title = {FABP3 methylation as a novel biomarker for the differentiation and classification of benign and malignant thyroid nodules — Europe PMC PMID:41019337},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41019337},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ceec16f74f25; sha256 76ee443d9b93dfadb41a506a42804b57975e65b912440deee543a9990ce4d711},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41019337. Agents can read the archived copy with the MCP tool read_document.